Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

ELEVATED LP(A) AND ESTABLISHED ATHEROSCLEROTIC CARDIOVASCULAR DISEASE

Clinical trials for ELEVATED LP(A) AND ESTABLISHED ATHEROSCLEROTIC CARDIOVASCULAR DISEASE explained in plain language.

Never miss a new study

Get alerted when new ELEVATED LP(A) AND ESTABLISHED ATHEROSCLEROTIC CARDIOVASCULAR DISEASE trials appear

Sign up with your email to follow new studies for ELEVATED LP(A) AND ESTABLISHED ATHEROSCLEROTIC CARDIOVASCULAR DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Targeted heart drug trial aims to help High-Risk communities

Disease control Ongoing

This study is testing whether a drug called pelacarsen can safely lower high levels of a protein called Lp(a), which is linked to heart disease. It focuses on Black/African American and Hispanic adults who already have heart disease and are receiving standard care. Participants r…

Matched conditions: ELEVATED LP(A) AND ESTABLISHED ATHEROSCLEROTIC CARDIOVASCULAR DISEASE

Phase: PHASE3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control

Last updated Mar 27, 2026 12:41 UTC